nefopam has been researched along with Chronic Disease in 5 studies
Nefopam: Non-narcotic analgesic chemically similar to ORPHENADRINE. Its mechanism of action is unclear. It is used for the relief of acute and chronic pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p26)
nefopam : A racemate comprising equal amounts of (R)- and (S)-nefopam. The hydrochloride is a centrally acting non-opiate analgesic commonly used for the treatment of moderate to severe pain.
5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine : A member of the class of benzoxazocines that is 3,4,5,6-tetrahydro-1H-2,5-benzoxazocine substituted by phenyl and methyl groups at positions 1 and 5 respectively.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Given preemptively, nefopam may be effective at improving postoperative pain management and at reducing the risk of developing postoperative chronic pain, because the drug has both analgesic and antihyperalgesic properties." | 7.75 | Long-term pain vulnerability after surgery in rats: prevention by nefopam, an analgesic with antihyperalgesic properties. ( Chateauraynaud, J; Laboureyras, E; Richebé, P; Simonnet, G, 2009) |
| "Given preemptively, nefopam may be effective at improving postoperative pain management and at reducing the risk of developing postoperative chronic pain, because the drug has both analgesic and antihyperalgesic properties." | 3.75 | Long-term pain vulnerability after surgery in rats: prevention by nefopam, an analgesic with antihyperalgesic properties. ( Chateauraynaud, J; Laboureyras, E; Richebé, P; Simonnet, G, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laboureyras, E | 1 |
| Chateauraynaud, J | 1 |
| Richebé, P | 1 |
| Simonnet, G | 1 |
| Evtiukhin, AI | 1 |
| Kuznetsova, OIu | 1 |
| Gorokhov, LV | 1 |
| Dunaevskiĭ, IV | 1 |
| Cronheim, G | 1 |
| Thiede, W | 1 |
| Minotti, V | 1 |
| Patoia, L | 1 |
| Roila, F | 1 |
| Basurto, C | 1 |
| Tonato, M | 1 |
| Pasqualucci, V | 1 |
| Maresca, V | 1 |
| Del Favero, A | 1 |
| Conigliaro, S | 1 |
| Rosà, R | 1 |
| Osimo, F | 1 |
| Fumagalli, E | 1 |
| Cavaliere, G | 1 |
| Arrigo, G | 1 |
2 trials available for nefopam and Chronic Disease
| Article | Year |
|---|---|
[The use of Oxadol in tablet form for the treatment of chronic pain syndrome in late-stage cancer patients].
Topics: Administration, Oral; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic Disease; Drug Ther | 2000 |
Double-blind evaluation of analgesic efficacy of orally administered diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic cancer pain.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Aspirin; Chronic Disea | 1989 |
3 other studies available for nefopam and Chronic Disease
| Article | Year |
|---|---|
Long-term pain vulnerability after surgery in rats: prevention by nefopam, an analgesic with antihyperalgesic properties.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Carrageenan; Chronic Disease; Fentanyl; Hyper | 2009 |
[An analgesic: Ajan].
Topics: Acute Disease; Analgesics; Chronic Disease; Female; Humans; Male; Nefopam; Oxazocines; Pain | 1979 |
[Chronic headache].
Topics: Acetylglucosaminidase; Adult; Aged; Aminopeptidases; CD13 Antigens; Chronic Disease; Female; Headach | 1987 |